Stock Events

Mycotopia Therapies 

$0.03
8
+$0+0% Tuesday 20:00

Statistics

Day High
0.04
Day Low
0.04
52W High
0.18
52W Low
0.01
Volume
20,877
Avg. Volume
4,552
Mkt Cap
312,832
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

30SepExpected
Q4 2019
Q1 2020
Q2 2020
Q4 2020
Q1 2021
Q2 2021
-0.17
-0.12
-0.06
0
Expected EPS
N/A
Actual EPS
-0.1749

People Also Follow

This list is based on the watchlists of people on Stock Events who follow TPIA. It's not an investment recommendation.
Alphabet
75225
GOOGL
Apple
65552
AAPL
Microsoft
61024
MSFT
Amazon
56508
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Compass Pathways
CMPS
Mkt Cap511.54M
Compass Pathways operates in the psychedelic medicine space, focusing on psilocybin therapy for mental health conditions, directly competing with Mycotopia's psychedelic therapy initiatives.
Mind Medicine
MNMD
Mkt Cap493.47M
Mind Medicine (MindMed) Inc. works on developing psychedelic-inspired therapies, including for anxiety and ADHD, which overlaps with Mycotopia Therapies' focus areas.
ATAI Life Sciences N.V.
ATAI
Mkt Cap218.14M
ATAI Life Sciences is a biotech company with a focus on psychedelic and non-psychedelic compounds for mental health, making it a direct competitor in the psychedelic therapy market.
GH Research
GHRS
Mkt Cap546.3M
GH Research PLC focuses on developing 5-MeO-DMT therapies for treatment-resistant depression, competing in the same psychedelic therapy space as Mycotopia.
Cybin
CYBN
Mkt Cap194.47M
Cybin Inc. is developing psychedelic compounds for various mental health conditions, positioning it as a competitor in the psychedelic-based therapeutic sector.
Revive Therapeutics
RVVTF
Mkt Cap3.99M
Revive Therapeutics Ltd. explores the use of psychedelics in treatments, including psilocybin for substance abuse, a market Mycotopia Therapies is also targeting.
Seelos Therapeutics
SEEL
Mkt Cap2.04M
Seelos Therapeutics, Inc. works on projects including ketamine-based therapies for major depressive disorder, competing in the broader psychedelic treatment market.

About

Mycotopia Therapies, Inc. focuses on psychedelics for the treatment of mental health issues. It provides psychedelic therapies for the treatment of post-traumatic stress disorder, severe anxiety, depression, palliative care, and serotonin syndrome. The company is based in Aventura, Florida. Mycotopia Therapies, Inc. is a subsidiary of EHAVE, Inc.
Show more...
CEO
Employees
1
Country
US
ISIN
US62846W1071

Listings

US
TPIA